Pharmacological characterization of the constitutively activated state of the serotonin 5-HT(2A) receptor

Annals of the New York Academy of Sciences

Volumn 861, Issue , 1998, Pages 140-145

  Herrick Davis, K ^a   Grinde, E ^a   Gauthier, C ^a   Teitler, M ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 CHLORO 2 (1 PIPERAZINYL)PYRAZINE; CLOZAPINE; CYPROHEPTADINE; INOSITOL PHOSPHATE; KETANSERIN; LYSINE; MESULERGINE; METHYSERGIDE; MUTANT PROTEIN; QUIPAZINE; RADIOLIGAND; SERINE; SEROTONIN; SEROTONIN 2C RECEPTOR; TRYPTAMINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; BINDING SITE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG SCREENING; MOUSE; NONHUMAN; PROTEIN CONFORMATION; RECEPTOR AFFINITY; RECEPTOR BINDING;

ANIMALIA;

EID: 0032417933     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10185.x     Document Type: Conference Paper

References (19)

1. 1. PARMA, J., L. DUPREZ, J. VANSANDE, P. COCHAUX, C. GERVY, J. MOCKEL, J. DUMONT & G. VASSART. 1993. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365: 649-651.
2. 2. RAO, W. R., G. B. COHEN & D. D. OPRIAN. 1994. Rhodopsin mutation 90D and a molecular mechanism for congenital night blindness. Nature 367: 639-642.
3. 3. SCHIPANI, E., K. KRUSE & H. JUPPNER. 1995. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268: 98-101.
4. 4. SHENKER, A., L. LAUE, S. KOSUGI, J. J. MERENDINO, T. MINEGISHI & G. B. CUTLER. 1993. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365: 652-654.
5. 1B-adrenergic receptor by all amino acid substitutions at a single site. J. Biol. Chem. 267: 1430-1433.
6. 1B-adrenergic receptor: Role of highly conserved polar amino acids in receptor activation. EMBO J. 15: 3566-3578.
7. 1-adrenergic receptor activation. Biochemistry 36: 633-639.
8. 8. TONACCHERA, M., J. VANSANDE, J. PARMA, L. DUPREZ, F. CETANI, S. COSTAGLIOLA, J. E. DUMONT & G. VASSART. 1996. TSH receptor and disease. Clin. Endocrinol. 44: 621-633.
9. 9. ROBINSON, P. R., G. B. COHEN, E. A. ZHUKOVSKY & D. D. OPRIAN. 1992. Constitutively active mutants of rhodopsin. Neuron 9: 719-725.
10. 10. SPALDING, T. A., E. S. BURSTEIN, H. BRAUNER-OSBORNE, D. HILL-EUBANKS & M. R. BRANN. 1995. Pharmacology of a constitutively active muscarinic receptor generated by random mutagenesis. J. Pharm. Exp. Ther. 275: 1274-1279.
11. 11. NANEVICZ, T., L. WANG, M. CHEN, M., ISHII & S. R. COUGHLIN. 1996. Thrombin receptor activating mutations. J. Biol. Chem. 271: 702-706.
12. 12. HOYER, D., D. E. CLARKE, J. R. FOZARD, P. R. HARTIG, G. R. MARTIN, A. MYLECHARNE, P. R. SAXENA & P. A. HUMPHREY. 1994. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46: 157-203.
13. 13. ROTH, B. L. 1994. Multiple serotonin receptors: Clinical and experimental aspects. Ann. Clin. Psychol. 6: 67-78.
14. 2C receptor. J. Neurochem. 69: 1138-1144.
15. 15. CHEN, C. & H. OKAYAMA. 1987. High efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7: 2745-2752.
16. 2-adrenergic receptor: Extending the ternary complex model. J. Biol. Chem. 268: 4625-4636
17. 2-adrenergic receptor. Mol. Pharm. 45: 390-394.
18. 18. BARKER, E. L., R. S. WESTPHAL, D. SCHMIDT & E. SANDERS-BUSH. 1994. Constitutively active 5-hydroxytryptamine receptors reveal novel inverse agonist activity of receptor ligands. J. Biol. Chem. 269: 11687-11690.
19. 19. BURNS, C. M., H. CHU, S. M. RUETER, L. K. HUTCHINSON, H. CANTON, E. SANDERS-BUSH & R. B. EMESON. 1997. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387: 303-308.